John Weinstein

Title: John Weinstein: Innovator in Gene Delivery Technologies

Introduction

John Weinstein is a prominent inventor based in Berkeley, CA. He has made significant contributions to the field of gene therapy through his innovative work on adeno-associated virus (AAV) variants. His research focuses on enhancing the effectiveness of gene delivery systems, which has important implications for medical treatments.

Latest Patents

John Weinstein holds a patent for "Adeno-associated virus variants and methods of use thereof." This patent describes recombinant adeno-associated virus (rAAV) virions that comprise a variant AAV capsid protein. The rAAV virions can exhibit greater infectivity of target cells, which is crucial for effective gene therapy. The patent also outlines methods for delivering gene products to target cells in individuals by administering the rAAV. Additionally, it provides techniques for generating rAAV virions with variant AAV capsid proteins derived from ancestral AAV capsid protein amino acid sequences. John Weinstein has 1 patent to his name.

Career Highlights

John Weinstein is affiliated with the University of California, where he conducts his research. His work has positioned him as a key figure in the development of advanced gene delivery systems. His innovative approaches have the potential to transform therapeutic strategies in various medical fields.

Collaborations

Throughout his career, John Weinstein has collaborated with notable colleagues, including David Stephen Ojala and Jorge Santiago-Ortiz. These collaborations have further enriched his research and contributed to advancements in gene therapy technologies.

Conclusion

John Weinstein's contributions to the field of gene delivery through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments and therapies.